Cancer Therapy Design Based on Pathway Information
基于通路信息的癌症治疗设计
基本信息
- 批准号:1068628
- 负责人:
- 金额:$ 37.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-15 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
ABSTRACTObjective: The main objective of this project is to develop a more systematic approach towards cancer treatment in order to a better success rate. Current cancer therapies suffer from two main drawbacks: (i) they do not take into account the genetic differences that exist between any two individuals, even if they are perfectly healthy; and (ii) they fail to pinpoint the precise malfunctioning in the cellular signaling that has led to the cancer seen in a particular patient. Intellectual Merit: The number of cells in a multi-cellular organism such as a human being is under very tight control and, under normal circumstances, there is some kind of a balance between new cell production and cell death. Roughly speaking, cancer results when there is excessive cell division or reduced cell death due to some malfunctioning in the cell number control system. What makes cancer therapy so difficult is that this malfunctioning can happen in many different ways and at many different locations. This project seeks to use prior information from the biological literature to model the normal cell signaling network as a digital circuit, whose output upon a possible breakdown can be used to pinpoint the precise breakdown location and accordingly tailor the therapy. The theoretical work will be experimentally validated. Broader Impacts: Since the research in this project specifically targets cancer therapy, its potential societal benefits in terms of ultimately saving human lives could be enormous. In addition, the methods developed here have the potential to impact other areas such as toxicological studies focusing on cellular response to different stresses. Every effort will be made to ensure that the benefits of the project reach a wide audience, including minorities and domestic students. In addition, the results of this project will lead to the publication of a new book.
摘要目的:该项目的主要目标是开发一种更系统的癌症治疗方法,以提高成功率。 目前的癌症疗法有两个主要缺点:(i)它们没有考虑到任何两个个体之间存在的遗传差异,即使他们非常健康;(ii)它们无法精确定位导致特定患者癌症的细胞信号传导中的精确故障。 智力优势:多细胞生物体(如人类)中的细胞数量受到非常严格的控制,在正常情况下,新细胞产生和细胞死亡之间存在某种平衡。 粗略地说,当细胞数量控制系统出现故障而导致细胞过度分裂或细胞死亡减少时,就会产生癌症。 癌症治疗之所以如此困难,是因为这种故障可能以许多不同的方式发生在许多不同的位置。该项目旨在利用生物学文献中的先验信息将正常细胞信号网络建模为数字电路,其在可能发生故障时的输出可用于精确定位故障位置并相应地定制治疗。理论工作将得到实验验证。更广泛的影响:由于该项目的研究专门针对癌症治疗,其在最终挽救人类生命方面的潜在社会效益可能是巨大的。此外,这里开发的方法有可能影响其他领域,如毒理学研究,重点是细胞对不同压力的反应。将尽一切努力确保该项目的好处惠及广大受众,包括少数民族和国内学生。此外,该项目的成果将导致出版一本新书。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aniruddha Datta其他文献
Robust and Optimal PID Controller Design
- DOI:
10.1016/s1474-6670(17)42581-x - 发表时间:
1997-06-01 - 期刊:
- 影响因子:
- 作者:
Ming-tzu Ho;Aniruddha Datta;L.H. Keel;S.P. Bhattacharyya - 通讯作者:
S.P. Bhattacharyya
In Vitro Flowering and High Xanthotoxin in Ammi majus L.
- DOI:
10.1007/bf03262956 - 发表时间:
2012-12-30 - 期刊:
- 影响因子:1.500
- 作者:
Madhumati Purohit;Deepshikha Pande;Aniruddha Datta;Prem S. Srivastava - 通讯作者:
Prem S. Srivastava
An addition to the endemic Indian radiation of Eutropis: Phylogenetic position of Eutropis dissimilis Hallowell (Squamata: Scincidae).
印度地方性辐射Eutropis的补充:Eutropis dissimilis Hallowell(有鳞目:Scincidae)的系统发育位置。
- DOI:
10.11646/zootaxa.4027.1.9 - 发表时间:
2015 - 期刊:
- 影响因子:0.9
- 作者:
Aniruddha Datta;V. Deepak;Chinta Sidharthan;A. J. Barley;K. Karanth - 通讯作者:
K. Karanth
Phylogeny of endemic skinks of the genus Lygosoma (Squamata: Scincidae) from India suggests an in situ radiation
印度石龙子属(Squamata:Scincidae)地方性石龙子的系统发育表明存在原位辐射
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Aniruddha Datta;Mewa Singh;K. Karanth - 通讯作者:
K. Karanth
Anti-tumor effects of cryptotanshinone (Csub19/subHsub20/subOsub3/sub) in human osteosarcoma cell lines
隐丹参酮(C₁₉H₂₀O₃)在人骨肉瘤细胞系中的抗肿瘤作用
- DOI:
10.1016/j.biopha.2022.112993 - 发表时间:
2022-06-01 - 期刊:
- 影响因子:7.500
- 作者:
Haswanth Vundavilli;Aniruddha Datta;Chao Sima;Jianping Hua;Rosana Lopes;Michael Bittner;Tasha Miller;Heather M. Wilson-Robles - 通讯作者:
Heather M. Wilson-Robles
Aniruddha Datta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aniruddha Datta', 18)}}的其他基金
I-Corps: Model-driven precision oncology for cancer therapy design
I-Corps:用于癌症治疗设计的模型驱动的精准肿瘤学
- 批准号:
2136215 - 财政年份:2021
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Cancer Therapeutics through Theory and Experiment: From Cell Lines to Canine Tumors Grown on the Back of Mice
通过理论和实验进行癌症治疗:从细胞系到小鼠背部生长的犬肿瘤
- 批准号:
1917166 - 财政年份:2019
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Identification of Drug Targets and Their Validation in Cancer Therapy Design
癌症治疗设计中药物靶标的识别及其验证
- 批准号:
1609236 - 财政年份:2016
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Exploiting The Heterogeneous Composition Of Tumor Tissue And The Altered Metabolism Of Tumor Cells For Cancer Therapy Design
利用肿瘤组织的异质组成和肿瘤细胞代谢的改变进行癌症治疗设计
- 批准号:
1404314 - 财政年份:2014
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Student Travel Award Support for GENSIPS'13
对 GENSIPS13 的学生旅行奖支持
- 批准号:
1342663 - 财政年份:2013
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Modeling and Control in Cancer Genomics
癌症基因组学的建模和控制
- 批准号:
0701531 - 财政年份:2007
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Controller Synthesis Subject to Structure and Order Constraints
受结构和阶次约束的控制器综合
- 批准号:
9903488 - 财政年份:1999
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Robust Adaptive Control Based on Kharitonov Theory and Its Extensions
基于Kharitonov理论及其扩展的鲁棒自适应控制
- 批准号:
9417004 - 财政年份:1995
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Robustness Quantification and Performance Improvement in Adaptive Control Systems
自适应控制系统的鲁棒性量化和性能改进
- 批准号:
9210726 - 财政年份:1992
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
相似海外基金
Single molecule resolution imaging of stressed DNA - the next paradigm shift in cancer therapy design?
受压 DNA 的单分子分辨率成像——癌症治疗设计的下一个范式转变?
- 批准号:
2747435 - 财政年份:2022
- 资助金额:
$ 37.18万 - 项目类别:
Studentship
I-Corps: Model-driven precision oncology for cancer therapy design
I-Corps:用于癌症治疗设计的模型驱动的精准肿瘤学
- 批准号:
2136215 - 财政年份:2021
- 资助金额:
$ 37.18万 - 项目类别:
Standard Grant
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
用于设计胰腺癌联合治疗的上皮-间质转化的最佳控制模型
- 批准号:
10450032 - 财政年份:2019
- 资助金额:
$ 37.18万 - 项目类别:
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
用于设计胰腺癌联合治疗的上皮-间质转化的最佳控制模型
- 批准号:
10670987 - 财政年份:2019
- 资助金额:
$ 37.18万 - 项目类别:
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
用于设计胰腺癌联合治疗的上皮-间质转化的最佳控制模型
- 批准号:
10218122 - 财政年份:2019
- 资助金额:
$ 37.18万 - 项目类别:
Precision lung cancer therapy design through multiplexed adapter measurement
通过多重适配器测量进行精准肺癌治疗设计
- 批准号:
10246394 - 财政年份:2017
- 资助金额:
$ 37.18万 - 项目类别:
Precision lung cancer therapy design through multiplexed adapter measurement
通过多重适配器测量进行精准肺癌治疗设计
- 批准号:
9759874 - 财政年份:2017
- 资助金额:
$ 37.18万 - 项目类别:
Design and evaluation of rapamycin loading liposome for lung cancer therapy
雷帕霉素负载肺癌治疗脂质体的设计与评价
- 批准号:
17K15513 - 财政年份:2017
- 资助金额:
$ 37.18万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Precision lung cancer therapy design through multiplexed adapter measurement
通过多重适配器测量进行精准肺癌治疗设计
- 批准号:
9388399 - 财政年份:2017
- 资助金额:
$ 37.18万 - 项目类别:
Design of a Femtosecond-Laser System for Novel Nanoparticle Cancer Therapy
用于新型纳米粒子癌症治疗的飞秒激光系统的设计
- 批准号:
475488-2015 - 财政年份:2016
- 资助金额:
$ 37.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral